The Federal Trade Commission (FTC) and the Food and Drug Administration (FDA) have jointly issued warning letters to seven sellers of unapproved and misbranded products, claiming they can treat or prevent the new coronavirus, COVID-19. The FTC says the companies have no evidence to back up their claims. Read a story from the FTC.
SMP Resource Center products often contain links to copyrighted material. The SMP Resource Center is providing these links as a convenience and for informational purposes in our efforts to report and educate on Medicare fraud; they do not constitute a guarantee, endorsement, or approval by SMP of any of the information available on the external site. SMP bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links. If you have any questions or concerns about the links provided, please contact the SMP Center at nliebau@smpresource.org.